Healthcare provider profile · identity verified

Philly Marie Wall, P.A.

Physician Assistant · CEDAR RAPIDS, IA · NPI 1497894117

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	604	155
Levothyroxine Sodium	Levothyroxine Sodium	296	69
Lisinopril	Lisinopril	252	69
Omeprazole	Omeprazole	230	67
Amlodipine Besylate	Amlodipine Besylate	215	67
Pantoprazole Sodium	Pantoprazole Sodium	191	57
Metoprolol Succinate	Metoprolol Succinate	165	40
Metformin Hcl	Metformin Hcl	147	36
Gabapentin	Gabapentin	136	39
Losartan Potassium	Losartan Potassium	132	35
Escitalopram Oxalate	Escitalopram Oxalate	126	38
Furosemide	Furosemide	120	33
Trazodone Hcl	Trazodone Hcl	107	30
Irbesartan	Irbesartan	103	28
Albuterol Sulfate Hfa	Albuterol Sulfate	102	34
Tamsulosin Hcl	Tamsulosin Hcl	96	24
Potassium Chloride	Potassium Chloride	84	23
Hydrochlorothiazide	Hydrochlorothiazide	82	25
Allopurinol	Allopurinol	81	21
Metformin Hcl Er	Metformin Hcl	75	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	26
Bupropion Xl	Bupropion Hcl	69	20
Rosuvastatin Calcium	Rosuvastatin Calcium	69	20
Montelukast Sodium	Montelukast Sodium	67	22
Alendronate Sodium	Alendronate Sodium	65	20
Famotidine	Famotidine	64	19
Jardiance	Empagliflozin	64	16
Sertraline Hcl	Sertraline Hcl	60	15
Clopidogrel	Clopidogrel Bisulfate	59	11
Simvastatin	Simvastatin	58	16
Spironolactone	Spironolactone	55	17
Glipizide Er	Glipizide	53	16
Mirtazapine	Mirtazapine	52	18
Tramadol Hcl	Tramadol Hcl	51	24
Pregabalin	Pregabalin	49	16
Ozempic	Semaglutide	48	suppressed
Glipizide	Glipizide	46	15
Meloxicam	Meloxicam	46	15
Pravastatin Sodium	Pravastatin Sodium	46	13
Atenolol	Atenolol	44	13
Duloxetine Hcl	Duloxetine Hcl	44	11
Eliquis	Apixaban	43	11
Finasteride	Finasteride	42	14
Metoprolol Tartrate	Metoprolol Tartrate	42	13
Ezetimibe	Ezetimibe	41	12
Prednisone	Prednisone	41	32
Carvedilol	Carvedilol	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Lovastatin	Lovastatin	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	12
Alprazolam	Alprazolam	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Torsemide	Torsemide	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Baclofen	Baclofen	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	13
Zolpidem Tartrate	Zolpidem Tartrate	21	11
Cephalexin	Cephalexin	20	13
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Amoxicillin	Amoxicillin	19	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Azithromycin	Azithromycin	19	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Januvia	Sitagliptin Phosphate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nystatin	Nystatin	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error